Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
David J. Wilber(Loyola University Chicago), for the ThermoCool AF Trial Investigators, Petr Neužil(Na Homolce Hospital), Scott Berry(Queen's University), Hugh Calkins(Johns Hopkins University), Christine Y. Liu, Carlo Pappone(San Raffaele University of Rome), Chandan Vinekar, Laurent Macle(Montreal Heart Institute), Vivek Y. Reddy(Mount Sinai Hospital), Emile G. Daoud(The Ohio State University Wexner Medical Center), Donald A. Berry(Berry & Associates (United States)), Andrea Natale(Texas Cardiac Arrhythmia), Matthew R. Reynolds(Harvard University Press), Giuseppe Augello(San Raffaele University of Rome), Angelo de Paola(Universidade Federal de São Paulo), Burr Hall(University of Rochester)
Cited by 1,170
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
|Circulation|2010|2.7k
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary
|Journal of the American College of Cardiology|2002|1.7k
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force Criteria
|European Heart Journal|2010|1.6k